Form D · Biotechnology
Summit Therapeutics Inc.
Miami, FL · CIK 0001599298
Offering snapshot reported Sep 26, 2024 · SEC filing
- Reported sold
- $235M Offering amount: $235M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 11, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 26, 2024 | Initial | $234,999,889 | No comparison | 17 | SEC filing |
| Jun 18, 2024 | Initial | $199,999,998 | No comparison | 2 | SEC filing |
| Nov 23, 2020 | Initial | $50,000,000 | No comparison | 3 | SEC filing |
| Jan 2, 2020 | Initial | $47,400,000 | No comparison | 1 | SEC filing |
| Jan 18, 2019 | Initial | $25,000,000 | No comparison | 1 | SEC filing |
| Mar 4, 2014 | Initial | $11,644,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-525024
Source: Form D, filed Sep 26, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Valerie Andrews | Director |
| Frank Armstrong | Director |
| Robert Booth | Director |
| Alessandra Cesano | Director |
| Kenneth Clark | Director |
| Stephen Davies | Director |
| Michael Paul Donaldson | Executive |
| Robert Duggan | Director, Executive |
| Glyn Edwards | Director, Executive |
| Daniel Elger | Executive |
| Rainer Erdtmann | Director |
| Camilla Graham | Executive |
| Jeff Huber | Director |
| Houbiers Jos | Executive |
| Ujwala Mahatme | Director |
| Jim Mellon | Director |
| David Johnathan Powell | Executive |
| Barry Price | Director |
| David Roblin | Executive |
| Mostafa Ronaghi | Director |
| Manmeet Soni | Director, Executive |
| Raymond Spencer | Executive |
| Ventzislav Stefanov | Director |
| Elaine Stracker | Director |
| David Wurzer | Director |
| Yu Xia | Director |
| Leopoldo Zambeletti | Director |
| Mahkam Zanganeh | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
601 Brickell Key Drive Suite 1000
Miami, FL, 33131
Miami, FL, 33131